# 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis

> **NCT03445884** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 42 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** 68Ga-NODAGA-E[c(RGDyK)]2

## Key facts

- **NCT ID:** NCT03445884
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-20
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03445884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03445884, "68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03445884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*